Valuation: ArcticZymes Technologies ASA

Market Cap 952M 98.4M 86.25M 79.72M 73.32M 138M 9.49B 141M 953M 374M 4.64B 369M 361M 16B P/E 2026 *
53.3x
P/E 2027 * 29.7x
Enterprise Value 675M 69.7M 61.09M 56.47M 51.93M 97.99M 6.72B 99.56M 675M 265M 3.29B 262M 256M 11.33B EV / Sales 2026 *
4.93x
EV / Sales 2027 * 3.96x
Free-Float
82.59%
Yield 2026 *
-
Yield 2027 * -
1 day-1.06%
1 week-1.84%
Current month-7.21%
1 month-7.21%
3 months-6.28%
6 months-13.26%
Current year-9.47%
1 week 18.4
Extreme 18.4
19.3
1 month 18.35
Extreme 18.35
20.9
Current year 18.3
Extreme 18.3
26.6
1 year 16.55
Extreme 16.55
31.4
3 years 12.34
Extreme 12.34
43.2
5 years 12.34
Extreme 12.34
109
10 years 3.5
Extreme 3.5
114.4
Manager TitleAgeSince
Chief Executive Officer - 2023-09-17
Director of Finance/CFO 51 2014-09-30
Chief Tech/Sci/R&D Officer 43 -
Director TitleAgeSince
Chairman 64 2024-06-25
Director/Board Member 62 2024-06-25
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
8/14/25 Buy

Director

2,852 0.0056%
6/4/25 Buy

Chief Operating Officer

3,400 0.0067%
5/14/25 Fiscal year

Chief Operating Officer

15,000 0.0294%
Change 5-day change 1-year change 3-year change Capi.($)
-1.06%-1.84%+10.03%-50.13% 98.4M
-2.73%-2.96%+48.62%+147.27% 1,023B
-1.67%-3.47%+52.00%+47.77% 599B
-0.44%+2.17%+33.88%+78.20% 448B
-0.75%+0.30%+28.32%+21.15% 326B
-1.52%-1.19%+33.38%+35.35% 278B
-1.70%-1.82%+20.26%+15.74% 258B
-0.58%+1.11%-20.89%-40.59% 222B
-0.58%+1.03%+23.55%+56.14% 197B
-0.80%+1.38%+23.09%+66.64% 165B
Average -0.79%-0.53%+25.22%+37.75% 351.52B
Weighted average by Cap. -0.88%-1.18%+35.16%+70.58%

Financials

2026 *2027 *
Net sales 137M 14.14M 12.4M 11.46M 10.54M 19.89M 1.36B 20.21M 137M 53.72M 667M 53.11M 51.95M 2.3B 162M 16.74M 14.67M 13.56M 12.47M 23.54M 1.61B 23.91M 162M 63.58M 790M 62.86M 61.49M 2.72B
Net income 18.12M 1.87M 1.64M 1.52M 1.39M 2.63M 181M 2.67M 18.14M 7.11M 88.33M 7.03M 6.88M 304M 32.59M 3.37M 2.95M 2.73M 2.51M 4.73M 325M 4.81M 32.62M 12.79M 159M 12.64M 12.37M 547M
Net Debt -278M -28.7M -25.16M -23.25M -21.39M -40.35M -2.77B -41M -278M -109M -1.35B -108M -105M -4.67B -310M -32.06M -28.1M -25.98M -23.89M -45.08M -3.09B -45.8M -311M -122M -1.51B -120M -118M -5.21B
Logo ArcticZymes Technologies ASA
Arcticzymes Technologies ASA is a Norway-based holding company providing support functions to the ArcticZymes AS subsidiary including distribution, administration, finance, Information Technology (IT) and quality assurance. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Employees
51
Date Price Change Volume
26-07-20 NOK 18.65 -1.06% 15,173
26-07-17 NOK 18.85 -1.31% 13,735
26-07-16 NOK 19.10 +2.14% 4,956
26-07-15 NOK 18.70 -1.32% 114,085
26-07-14 NOK 18.95 -0.26% 23,875
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
18.65NOK
Average target price
31.00NOK
Spread / Average Target
+66.22%

Quarterly revenue - Rate of surprise